Ascorbate
Sponsors
Beersheva Mental Health Center, Joseph J. Cullen, MD, FACS, Joseph J. Cullen, Mohammed Milhem, MBBS, Mohammed Milhem
Conditions
Acute SchizophreniaBone SarcomaGBMGlioblastomaGlioblastoma MultiformeMetastatic Bone SarcomaMetastatic Bone TumorMetastatic Pancreatic Adenocarcinoma
Early Phase 1
Phase 1
A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
CompletedNCT01752491
Start: 2013-04-01End: 2019-11-15Updated: 2024-12-20
Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I
CompletedNCT01852890
Start: 2014-01-31End: 2025-10-14Updated: 2025-10-24
High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas
CompletedNCT03508726
Start: 2019-06-27End: 2024-06-02Updated: 2024-06-27
High Dose Ascorbic Acid for Plasma Cell Disorders
CompletedNCT03602235
Start: 2019-03-05End: 2025-09-03Updated: 2025-10-21
Phase 2
Gemcitabine Plus Ascorbate for Sarcoma in Adults
TerminatedNCT03468075
Start: 2018-07-11End: 2020-10-19Updated: 2020-12-10
A Clinical Trial Evaluating the Effect of Pharmacological Ascorbate on Radiation Therapy for Pancreatic Cancer Patients
WithdrawnNCT03541486
Start: 2025-12-31End: 2030-12-31Updated: 2025-03-10
Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic Cancer
RecruitingNCT06018896
Start: 2023-08-25End: 2026-08-15Target: 20Updated: 2024-06-06